Largest pharmaceutical companies in the United States by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Johnson & Johnson leads the 36 pharmaceutical companies in the United States ranked by revenue, at ZAR 1.66T, ahead of Eli Lilly (ZAR 1.15T) and Merck & Co (ZAR 1.14T). Figures as of 20 Nov 2026, 22:51 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 36
- First
- Johnson & JohnsonZAR 1.66T
- Median
- ZAR 24.3B
- Combined market value
- ZAR 65.69T
- Countries
- 1
- Not ranked
- 8no revenue on file
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | ZAR 1.66T | ZAR 11.45T | ZAR 4,756.38 | 1.25% up | 31% up | ||
| 2 | Eli LillyLLY · Health Care | ZAR 1.15T | ZAR 21.1T | ZAR 23,689.74 | 0.30% down | 28% up | ||
| 3 | Merck & CoMRK · Health Care | ZAR 1.14T | ZAR 5.8T | ZAR 2,351.55 | 0.69% up | 36% up | ||
| 4 | PfizerPFE · Health Care | ZAR 1.1T | ZAR 2.75T | ZAR 481.85 | 0.51% down | 10% up | ||
| 5 | AbbVieABBV · Health Care | ZAR 1.08T | ZAR 8.9T | ZAR 5,033.00 | 0.94% up | 20% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | ZAR 847.5B | ZAR 2.11T | ZAR 1,034.03 | 0.79% up | 26% up | ||
| 7 | Abbott LaboratoriesABT · Health Care | ZAR 779.5B | ZAR 3.14T | ZAR 1,811.32 | 0.84% down | 19% down | ||
| 8 | Regeneron PharmaceuticalsREGN · Health Care | ZAR 252.2B | ZAR 1.67T | ZAR 16,190.89 | 0.19% down | 22% up | ||
| 9 | ViatrisVTRS · Health Care | ZAR 251.5B | ZAR 395.8B | ZAR 345.21 | 1.26% down | 90% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | ZAR 211.1B | ZAR 2.3T | ZAR 9,056.94 | 1.08% down | 22% up | ||
| 11 | ZoetisZTS · Health Care | ZAR 166.5B | ZAR 565.3B | ZAR 1,391.20 | 2.08% down | 34% down | ||
| 12 | Elanco Animal HealthELAN · Health Care | ZAR 82.9B | ZAR 226.2B | ZAR 452.65 | 2.09% down | 18% up | ||
| 13 | Alnylam PharmaceuticalsALNY · Health Care | ZAR 65.3B | ZAR 338.7B | ZAR 2,529.16 | 2.71% down | 66% down | ||
| 14 | BioMarin PharmaceuticalBMRN · Health Care | ZAR 56.6B | ZAR 205.8B | ZAR 1,062.35 | 1.64% down | 12% up | ||
| 15 | United TherapeuticsUTHR · Health Care | ZAR 56B | ZAR 415.5B | ZAR 9,755.26 | 0.78% down | 18% up | ||
| 16 | Amneal PharmaceuticalsAMRX · Health Care | ZAR 53.1B | ZAR 129.4B | ZAR 371.41 | 1.26% down | 79% up | ||
| 17 | Royalty PharmaRPRX · Health Care | ZAR 41.8B | ZAR 692.1B | ZAR 1,203.73 | 1.08% up | 74% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | ZAR 30.4B | ZAR 82.9B | ZAR 992.18 | 3.27% down | 26% down | ||
| 19 | Legend BiotechLEGN · Health Care | ZAR 18.1B | ZAR 52B | ZAR 268.18 | 5.28% down | 43% down | ||
| 20 | Madrigal PharmaceuticalsMDGL · Health Care | ZAR 16.9B | ZAR 154.9B | ZAR 6,666.70 | 4.45% down | 28% down | ||
| 21 | Ionis PharmaceuticalsIONS · Health Care | ZAR 16.6B | ZAR 77.8B | ZAR 467.43 | 2.35% down | 64% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | ZAR 14.6B | ZAR 102.8B | ZAR 727.52 | 5.22% down | 8% up | ||
| 23 | Corcept TherapeuticsCORT · Health Care | ZAR 13.4B | ZAR 122.4B | ZAR 1,118.80 | 2.09% down | 16% down | ||
| 24 | Axsome TherapeuticsAXSM · Health Care | ZAR 11.2B | ZAR 119.7B | ZAR 2,274.87 | 4.66% down | 9% down | ||
| 25 | TG TherapeuticsTGTX · Health Care | ZAR 10.8B | ZAR 168.4B | ZAR 1,113.87 | 2.37% down | 103% up | ||
| 26 | InsmedINSM · Health Care | ZAR 10.7B | ZAR 545.2B | ZAR 2,485.37 | 2.17% down | 27% down | ||
| 27 | Mirum PharmaceuticalsMIRM · Health Care | ZAR 9.2B | ZAR 110.4B | ZAR 1,690.50 | 0.65% up | 35% up | ||
| 28 | BridgeBio PharmaBBIO · Health Care | ZAR 8.8B | ZAR 260.5B | ZAR 1,337.03 | 2.75% down | 15% up | ||
| 29 | Travere TherapeuticsTVTX · Health Care | ZAR 8.6B | ZAR 79.3B | ZAR 826.52 | 2.69% down | 39% up | ||
| 30 | Ligand PharmaceuticalsLGND · Health Care | ZAR 4.7B | ZAR 100.9B | ZAR 5,044.43 | 0.03% down | 44% up | ||
| 31 | Rhythm PharmaceuticalsRYTM · Health Care | ZAR 3.3B | ZAR 137B | ZAR 1,975.92 | 3.80% down | 15% up | ||
| 32 | CytokineticsCYTK · Health Care | ZAR 1.5B | ZAR 124.4B | ZAR 893.00 | 1.32% down | 21% down | ||
| 33 | Protagonist TherapeuticsPTGX · Health Care | ZAR 809.2M | ZAR 139.3B | ZAR 2,134.89 | 2.11% down | 45% up | ||
| 34 | Dianthus TherapeuticsDNTH · Health Care | ZAR 35.8M | ZAR 83.7B | ZAR 1,486.86 | 0.33% down | 105% up | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | ZAR 0 | ZAR 156.1B | ZAR 1,643.73 | 4.26% down | 302% up | ||
| 36 | Praxis Precision MedicinesPRAX · Health Care | ZAR 0 | ZAR 147.7B | ZAR 5,283.24 | 3.37% down | 83% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 17.5856 ZAR). 8 companies have no revenue on file and are not ranked here.
Questions and answers
Which pharmaceutical companies in the United States rank first by revenue?
Johnson & Johnson (ZAR 1.66T), Eli Lilly (ZAR 1.15T) and Merck & Co (ZAR 1.14T) are the top three of the 36 pharmaceutical companies in the United States ranked by revenue as of 20 Nov 2026, 22:51 UTC.
How many pharmaceutical companies in the United States are in this ranking?
36 are ranked by revenue. 8 more have no revenue on file and are left out rather than ranked at zero.
What are these pharmaceutical companies in the United States worth together?
The 36 pharmaceutical companies in the United States ranked by revenue have a combined market value of ZAR 65.69T as of 20 Nov 2026, 22:51 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by revenue”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.